Mirum Pharmaceuticals (MIRM) Leases: 2020-2025
Historic Leases for Mirum Pharmaceuticals (MIRM) over the last 6 years, with Sep 2025 value amounting to $8.5 million.
- Mirum Pharmaceuticals' Leases fell 6.95% to $8.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.5 million, marking a year-over-year decrease of 6.95%. This contributed to the annual value of $8.7 million for FY2024, which is 575.62% up from last year.
- As of Q3 2025, Mirum Pharmaceuticals' Leases stood at $8.5 million, which was down 4.99% from $8.9 million recorded in Q2 2025.
- In the past 5 years, Mirum Pharmaceuticals' Leases ranged from a high of $9.1 million in Q3 2024 and a low of $300,000 during Q2 2022.
- Moreover, its 3-year median value for Leases was $7.7 million (2025), whereas its average is $5.3 million.
- In the last 5 years, Mirum Pharmaceuticals' Leases crashed by 83.33% in 2022 and then skyrocketed by 1,026.91% in 2025.
- Quarterly analysis of 5 years shows Mirum Pharmaceuticals' Leases stood at $1.6 million in 2021, then fell by 8.80% to $1.4 million in 2022, then dropped by 10.27% to $1.3 million in 2023, then soared by 575.62% to $8.7 million in 2024, then fell by 6.95% to $8.5 million in 2025.
- Its Leases was $8.5 million in Q3 2025, compared to $8.9 million in Q2 2025 and $7.7 million in Q1 2025.